POLA PERESEPAN OBAT PADA PASIEN COVID-19 DENGAN PENYERTA KARDIOVASKULER DI RST DR.SOEPRAOEN
Total View This Week0
Total View This Week0
Institusion
Politeknik Kesehatan RS Dr Soepraoen Kesdam V
Author
Cahyaningrum, Ayu Wastuti
Subject
Datestamp
2023-08-23 03:47:13
Abstract :
Dari total kasus yang positif COVID-19, sebanyak 1.488 pasien tercatat memiliki penyakit penyerta. Gangguan kardiovaskuler merupakan komplikasi pada pasien COVID-19. Peneliti menggunakan metode observasional non eksperimental secara deskriptif. Pengamatan dilakukan secara retrospektif pendekatan cross sectional. Pengambilan data sekunder dari lembar resep pengobatan pasien COVID-19 periode Juli 2021 ? September 2021 diperoleh sampel 51 pasien memenuhi kriteria inklusi. Berdasarkan hasil penelitian, diperoleh karakteristik usia dan jenis kelamin pasien COVID-19 terbanyak usia 45-65 tahun sebanyak 23 orang (45,1%), pasien laki-laki sebanyak 28 orang (54,9%). Peresepan antibiotik Meropenem sebanyak 34 peresepan (14,34%), berdasarkan penggolongan obat untuk terapi COVID-19 paling banyak Vitamin 81 peresepan (34,18%). peresepan Atorvastatin sebanyak 27 peresepan dan Candesartan sebanyak 27 peresepan (27,56%), golongan obat kardiovaskuler paling banyak golongan Disiplidemia 30 peresepan (30,50%). Terapi kombinasi 6 golongan obat sebanyak 15 peresepan (29,4%) dengan pemberian terbanyak yaitu Antibiotik + Vitamin + Antivirus + Antikoagulan + Kortikosteroid + Disiplidemia. ABSTRACT Of the total positive cases of COVID-19, 1,488 patients were recorded to have co-morbidities. Cardiovascular disorders are a complication in COVID- 19 patients. The researcher used a descriptive non-experimental observational method. Observations were carried out retrospectively with a cross sectional approach. Secondary data collection from the COVID-19 patient prescription sheet for the period July 2021 ? September 2021, obtained a sample of 51 patients who met the inclusion criteria. Based on the results of the study, the age and sex characteristics of COVID-19 patients were 23 people (45.1%), most of the patients were 28 people (54.9%). There were 34 prescriptions for the antibiotic Meropenem (14.34%), based on the classification of drugs for the treatment of COVID- 19 with the most Vitamin 81 prescriptions (34.18%). There are 27 prescriptions for Atorvastatin and 27 prescriptions for Candesartan (27.56%), the most cardiovascular drug group is the Disciplidemia group with 30 prescriptions (30.50%). Combination therapy of 6 drug classes was 15 prescriptions (29.4%) with the most administration, namely Antibiotics + Vitamins + Antivirus + Anticoagulants + Corticosteroids + Disciplidemia.
Dari total kasus yang positif COVID-19, sebanyak 1.488 pasien tercatat memiliki penyakit penyerta. Gangguan kardiovaskuler merupakan komplikasi pada pasien COVID-19. Peneliti menggunakan metode observasional non eksperimental secara deskriptif. Pengamatan dilakukan secara retrospektif pendekatan cross sectional. Pengambilan data sekunder dari lembar resep pengobatan pasien COVID-19 periode Juli 2021 ? September 2021 diperoleh sampel 51 pasien memenuhi kriteria inklusi. Berdasarkan hasil penelitian, diperoleh karakteristik usia dan jenis kelamin pasien COVID-19 terbanyak usia 45-65 tahun sebanyak 23 orang (45,1%), pasien laki-laki sebanyak 28 orang (54,9%). Peresepan antibiotik Meropenem sebanyak 34 peresepan (14,34%), berdasarkan penggolongan obat untuk terapi COVID-19 paling banyak Vitamin 81 peresepan (34,18%). peresepan Atorvastatin sebanyak 27 peresepan dan Candesartan sebanyak 27 peresepan (27,56%), golongan obat kardiovaskuler paling banyak golongan Disiplidemia 30 peresepan (30,50%). Terapi kombinasi 6 golongan obat sebanyak 15 peresepan (29,4%) dengan pemberian terbanyak yaitu Antibiotik + Vitamin + Antivirus + Antikoagulan + Kortikosteroid + Disiplidemia. ABSTRACT Of the total positive cases of COVID-19, 1,488 patients were recorded to have co-morbidities. Cardiovascular disorders are a complication in COVID- 19 patients. The researcher used a descriptive non-experimental observational method. Observations were carried out retrospectively with a cross sectional approach. Secondary data collection from the COVID-19 patient prescription sheet for the period July 2021 ? September 2021, obtained a sample of 51 patients who met the inclusion criteria. Based on the results of the study, the age and sex characteristics of COVID-19 patients were 23 people (45.1%), most of the patients were 28 people (54.9%). There were 34 prescriptions for the antibiotic Meropenem (14.34%), based on the classification of drugs for the treatment of COVID- 19 with the most Vitamin 81 prescriptions (34.18%). There are 27 prescriptions for Atorvastatin and 27 prescriptions for Candesartan (27.56%), the most cardiovascular drug group is the Disciplidemia group with 30 prescriptions (30.50%). Combination therapy of 6 drug classes was 15 prescriptions (29.4%) with the most administration, namely Antibiotics + Vitamins + Antivirus + Anticoagulants + Corticosteroids + Disciplidemia.
Download
book
BibTex
Latex, Jabref
cloud_download
Original Resource
url resource Institution
